AC Immune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.About ACIU
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
CEOAndrea Pfeifer
CEOAndrea Pfeifer
Employees172
Employees172
HeadquartersLausanne, Vaud
HeadquartersLausanne, Vaud
Founded2003
Founded2003
Employees172
Employees172
ACIU Key Statistics
Market cap167.71M
Market cap167.71M
Price-Earnings ratio-2.91
Price-Earnings ratio-2.91
Dividend yield—
Dividend yield—
Average volume124.57K
Average volume124.57K
High today$1.73
High today$1.73
Low today$1.65
Low today$1.65
Open price$1.70
Open price$1.70
Volume68.80K
Volume68.80K
52 Week high$4.98
52 Week high$4.98
52 Week low$1.43
52 Week low$1.43
ACIU News
Simply Wall St 5d
Individual investors among AC Immune SA's largest shareholders, saw gain in holdings value after stock jumped 11% last weekAdvertisement Key Insights AC Immune's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larg...
People also own
Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.